1 asset in Infantile Myofibromatosis
Therapeutic assets addressing Infantile Myofibromatosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Selpercatinib Infantile Myofibromatosis | Eli Lilly and Company | P1/2 | CCC (48) |